T he need for emergency cardiac surgery has decreased dramatically from 6% to 10%, 1 during the era of balloon angioplasty, to 0.1% to 0.4% in the current era of stents because of the many advances in technology, techniques, adjunctive pharmacotherapy, and operator experience. [2][3] [4] Despite this progress, concerns remain about performing percutaneous coronary intervention (PCI) at centers without on-site surgical backup, especially regarding nonprimary PCI for conditions other than ST-segment-elevation myocardial infarction (STEMI). Because primary PCI confers longer survival and timely reperfusion, increased access to primary PCI was encouraged. Subsequently, numerous studies showed that safety and efficacy of primary PCI are similar in centers with and without on-site surgical capability. 4, 5 Current American College of Cardiology Foundation/ American Heart Association/Society for Cardiovascular Angiography and Interventions guidelines recommend that primary PCI for STEMI be performed at centers without on-site surgical backup (class IIa, level of evidence: B).
Study Selection
Studies that met each of following criteria were considered eligible for meta-analysis: performed before February 2015; complications and clinical outcomes of PCI, including all-cause mortality or need of emergency surgery, from a center without on-site surgical backup were clearly reported; the outcomes were compared with a center with on-site surgical backup; for studies of primary PCI, a clear STEMI definition was reported; and had a randomized, controlled trial (RCT) or nonrandomized, prospective, observational study design. Eligible nonrandomized prospective observational studies adjusted appropriately for baseline differences between centers with or without on-site surgical backup (eg, propensity score-based adjustment, matching, or covariate adjustment). Studies that reported outcomes of PCI without a comparison or control group were not included.
Data Extraction and Quality Assessment
Summary data as reported in the published articles were analyzed. A standardized form was used to extract study characteristics, study design, number of study patients, type of PCI (primary or nonprimary), age, and clinical and angiographic eligibility criteria, including clinical diagnosis, definition of STEMI, proportion with 3-vessel disease or left main vessel intervention, and proportion of cardiovascular risk factors. The rates of all-cause mortality, in-hospital mortality, early mortality, late mortality, need for emergency surgery, complications related to PCI (stroke, cardiogenic shock, coronary dissection, cardiac tamponade, and recurrent myocardial infarction) were collected, along with the outcome definitions, as reported on an intention-to-treat basis. Patients with facilitated PCI or rescue PCI were not included in the STEMI group; such patients were likely to be included as non-STEMI patients in the nonprimary PCI group. For studies that enrolled both primary and nonprimary PCI patients, group size and number of events were separately extracted, according to the primary or nonprimary PCI category.
The quality of eligible studies was assessed by using the Cochrane Collaboration's tool for assessing the risk of bias for RCTs, the Newcastle-Ottawa Scale, and the strengthening the reporting of observational studies in epidemiology checklist for nonrandomized prospective observational studies. We did not exclude individual studies from the analysis based on thresholds of Newcastle-Ottawa Scale or strengthening the reporting of observational studies in epidemiology checklists. The primary outcome was the all-cause mortality rate at the longest available follow-up. Secondary outcomes included the need for emergency surgery related to the PCI; all-cause mortality stratified by time of death (definitions: early mortality occurred within 30 days of the index procedure and late mortality occurred after 30 days); and complications of PCI (stroke, cardiogenic shock, coronary dissection, cardiac tamponade, and recurrent myocardial infarction). If data were duplicated among studies, the most recent study was used.
Data Synthesis and Analysis
Primary and secondary outcomes were analyzed using mixed-effects models. Odds ratios (ORs) with 95% confidence intervals (CIs) were presented as summary statistics. Because all included studies showed heterogeneity regarding study protocol and populations, fixed-effects models were only used for sensitivity analyses to check whether these models yielded similar results. The pooled ORs and 95% CIs were calculated by using the restricted maximum likelihood method for mixed-effects and the Mantel-Haenszel method for fixed effects. 8 Because primary study designs and clinical practice patterns, especially revascularization methods (balloon angioplasty, bare metal stent, first-or second-generation drug-eluting stents [DES] ), changed progressively, we evaluated the impact of the publication date on the overall pooled ORs for all-cause mortality rate by using cumulative meta-analysis. Cumulative meta-analysis updates the pooled estimate of the treatment effect each time the results of a new study are added. Therefore, cumulative meta-analysis repeats the pooled analysis whenever new studies become available for inclusion. Because all of the included studies in the cumulative meta-analysis had the same comparison groups, cumulative pooled-effect estimates up to the time point of last study inclusion could reflect temporal trends in effect size (OR).
All patients and outcomes were analyzed separately by type of PCI (primary PCI or nonprimary PCI) according to the originally assigned group. Statistical heterogeneity was quantified by using the 9 was assessed by funnel plot asymmetry and the Egger and Begg tests; when visual asymmetry of the funnel plot was suspected, the trim-and-fill method was used to estimate the number of missing studies and to calculate a corrected OR, as if these studies were present. The influence of an individual study was explored by estimating pooled ORs, with stepwise exclusion of 1 study.
Subgroup analyses were performed to determine whether effects differed across subgroups. These subgroups analyses were analyzed: (1) study design (RCT or prospective observational study); (2) 
Results

Search Results
We identified 2265 citations. Among these citations, 39 articles were retrieved for full review; 23 met inclusion criteria ( Figure 1) . 2, 3, 7, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] Characteristics of the 16 excluded studies, after full-article review, are summarized in the online-only Data Supplement. The final 23 studies included 1 101 123 patients; 
Study Characteristics and Risk of Bias Within Studies
The main characteristics of the 23 individual studies are summarized in the Table. Nineteen studies were prospective observational cohort or matched case-control studies 7, [10] [11] [12] [13] [14] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] and 4 were RCTs. 2, 3, 15, 16 All the nonrandomized studies reported adjusted rates of clinical outcomes by using propensity score-based adjustment, matching, or covariate adjustment. Eight studies exclusively enrolled STEMI patients who underwent primary PCI. 11, 12, 15, 19, 20, 23, 25, 29 Conversely, 6 studies exclusively evaluated patients after nonprimary PCI (elective or urgent PCI) for indications other than STEMI 2, 3, 10, 16, 21, 26 ; 9 studies evaluated both primary and nonprimary PCI pat ients. 13, 14, 17, 18, 22, 24, 27, 28 All 9 studies reported group size and clinical outcomes according to PCI type. The proportion with 3-vessel disease was relatively higher in 7 studies than in other studies, 7, 13, 15, 17, 21, 22, 27 ranging from 33.6% to 61.5% across these studies. The proportion with left main vessel PCI was reported by only 8 studies and was very low, ranging from 0.4% to 3.8% across these studies.
Tables II and III in the online-only Data Supplement summarize the bias risk assessment by study design. All the RCTs had no substantial risk of bias in random sequence generation and relatively high methodological quality. Although no RCT was double blinded, all trials defined clinical end points objectively. Therefore, the outcomes were unlikely to be influenced by the lack of blinding. All the nonrandomized studies met at least 17 variables of the strengthening the reporting of observational studies in epidemiology checklist; Table III in the online-only Data Supplement presents results of the Newcastle-Ottawa Scale.
Mortality and Emergency Surgery After Primary PCI
For 133 574 patients who underwent primary PCI for STEMI, the observed rates of all-cause mortality in pooled analysis were 7.2% and 4.8%, respectively, for centers with and without on-site surgery and did not differ based on pooled analysis using a mixed-effects model (pooled OR, 0.99; 95% CI, 0.91-1.07; P=0.729; Figure 2A at TEL AVIV UNIV on September 28, 2015 http://circ.ahajournals.org/ Downloaded from Observed rates of emergency surgery in pooled analysis were 2.4% and 1.5%, respectively, for centers with and without on-site surgery. Pooled analysis showed no differences in these rates, but moderate heterogeneity (pooled OR, 0.76; 95% CI, 0.56-1.01; P=0.062; I 2 =42.5%; Figure 3A ). Because follow-up periods differed, separate pooled analyses were performed for early (within 30 days) and late (after 30 days) all-cause mortality. For primary PCI, neither early mortality (pooled OR, 0.99; 95% CI, 0.91-1.08; P=0.900; I 
Mortality and Emergency Surgery After Nonprimary PCI
For 967 549 patients who underwent nonprimary PCI for conditions other than STEMI, the observed rates of all-cause mortality in pooled analysis were 2.1% and 1.6%, respectively, for centers with and without on-site surgery, and did not differ based on pooled analysis using a mixed-effects model (pooled OR, 1.15; 95% CI, 0.94-1.41; P=0.172; I 2 =67.5%; Figure 2B ). Because of the considerable heterogeneity across the studies, pooled analysis with a fixed-effects model was considered inappropriate.
For such patients, observed rates of emergency surgery in pooled analysis were relatively low (0.8%, and. 0.5% respectively, for centers with and without on-site surgery) and did not differ according to pooled analysis (pooled OR, 1.14; 95% CI, 0.62-2.13; P=0.669; I 2 =81.7%; Figure 3B ). Symmetrical funnel plots of all-cause mortality and emergency surgery, with the support of the Egger and Begg tests, indicated no apparent publication bias ( Figure 4B and 4D). The pooled-effect estimates for all-cause mortality or emergency surgery were not substantially influenced by any individual study (Figures IB and IIB in the online-only Data Supplement).
For patients who underwent nonprimary PCI, pooled analysis revealed considerable heterogeneity; therefore, restricted pooled analyses were also performed including only RCTs. 
Temporal Trends of Mortality Rates After PCI
The results of cumulative meta-analysis, which sorts trials chronologically, revealed that temporal trends of the effect size (OR) for all-cause mortality differed by indication for PCI. The pooled-effect size for all-cause mortality after primary PCI did not shift over time, despite the differences in practice patterns or 
Complications of PCI
The overall frequencies of serious complications of PCI were very low (stroke, 0.5%; aortic dissection, 0.3%; cardiac tamponade, 0.1%; and recurrent myocardial infarction, 1.4%), with the exception of cardiogenic shock (4.6%; Figure 7 ). These frequencies did not differ between centers with and without on-site surgery.
Subgroup Analyses
The results of subgroup analyses of the outcome all-cause mortality resembled those of the overall analyses and showed no differences between centers with and without on-site surgery ( Figure 8 ). No significant interaction was observed across the various subgroups.
Discussion
We performed an updated systemic review and meta-analysis that compared clinical outcomes and complications after PCI between centers with or without on-site surgical backup. The principal findings were as follows. (1) After primary PCI for STEMI, centers without on-site surgery did not differ from centers with on-site surgery in the rates of all-cause mortality, emergency surgery, and serious complications of PCI. In addition, effect size did not change over time despite substantial temporal changes in practice patterns, revascularization methods, and adjunctive pharmacotherapy for STEMI. Heterogeneity across the studies was minimal and publication bias was not suspected. (2) Similarly, after nonprimary PCI for conditions other than STEMI, the rates of all-cause mortality, emergency surgery, and serious complications of PCI did not differ in centers with and without on-site surgery. Publication bias was not suspected, and these findings were consistent across various subgroups. Although the overall pooled analysis had considerable heterogeneity for all-cause mortality and emergency surgery, a restricted pooled analysis of only RCTs showed similar findings with much lowered heterogeneity. (3) Interestingly, after 2007 to 2008, there was a clear trend in the effect size (OR), from greater toward equivalent risk, for all-cause mortality following nonprimary PCI in centers without on-site surgery. (4) Regardless of the presence of on-site surgery, the overall frequencies of emergency surgery and serious complications of PCI were very low, especially after nonprimary PCI. The equivalence of centers with and without on-site surgery in clinical outcomes and complication rates after nonprimary PCI suggests widespread standardization of PCI technique, devices, and clinical practice patterns. Furthermore, the equivalent outcomes after primary PCI supports the current strategy of increasing access to cardiac catheterization laboratories and consequent reperfusion.
Reappraisal of the Rationale for On-Site Surgery
During the initial years of coronary balloon angioplasty, ≈6.6% of patients required emergency surgery because of procedure-related complications. 4 Thereafter, improvements in techniques and devices, wide use of more advanced DES, and increasing operator experience were followed by decreasing rates of emergency surgery to 0.14% to 0.37%. 4, 24 In addition, because primary PCI has been proven to produce significantly better outcomes than thrombolysis, improved access to primary PCI has become more important. Moreover, increasing evidence supports noninferior clinical outcomes of PCI at centers without on-site surgery, in comparison with centers with on-site surgery. 12, 15, 19, 23 These aforementioned factors have contributed to the expansion of PCIs performed in centers without on-site surgery.
Primary PCI Without On-Site Surgery
Previous meta-analyses 6, 30 and the current meta-analysis consistently showed that the safety (in-hospital mortality and need for emergency surgery) and efficacy (procedural success and longer-term survival) of primary PCI performed without on-site surgery was similar to that performed with on-site surgery. The current meta-analysis found equivalent clinical outcomes, and serious complications of PCI, as well, that were not evaluated in previous analyses. It should be noted that the rates of emergency surgery were ≈0.9% higher in centers with on-site surgery despite the lack of statistical significance. The tendency of higher emergency surgery rates in centers with on-site surgical backup could reflect lower thresholds for emergency surgery in these centers. This explanation is supported by the similar frequencies of serious PCI complications, the main indications for emergency surgery.
Considering these results, rather than mandating on-site surgical backup for possible emergent conditions, the following potential strategies to improve patient outcomes should be encouraged: maintaining the quality of care in individual PCI centers (such as a global quality assurance program); reducing total ischemic time (both door-to-balloon time and pain-to-hospital time); improving community recognition of and response to cardiac events; and optimizing posttreatment follow-up, including secondary prevention and cardiac rehabilitation.
4,31
Nonprimary or Elective PCI Without On-Site Surgery
For nonprimary PCI, the debate regarding the need for onsite surgical backup is more complex than for primary PCI; neither the necessity for rapid access nor anticipated survival benefits require performing nonprimary PCI at centers without on-site surgery. 4 The expansion of nonprimary PCI to centers without on-site surgery has advantages and disadvantages. The advantages may include greater hospital choice, greater opportunity to remain close to home, more continuity of care with local physicians, closer postoperative follow-up, and enhanced secondary prevention. However, these advantages should be balanced with potential disadvantages, such as the incremental risks of life-threatening complications and resultant mortality. 2, 4, 32 Data about clinical outcomes in centers without on-site surgery have been conflicting. Analysis of Medicare administrative data by Wennberg et al 14 generated concern about the safety of PCI without on-site surgical backup. They reported significantly higher mortality rates in hospitals without on-site surgery than in those with on-site surgery (4.6% versus 2.8%; adjusted OR, 1.38; 95% CI, 1.14-1.67) among the 589 522 patients who underwent nonprimary or rescue PCI. However, caution is warranted in interpreting these results. Because the study periods ranged from 1999 to 2001, the results may not reflect contemporary practices for nonprimary PCI, such as more advanced and improved technologies, including DES and pharmacotherapy that improve the safety of PCI. Moreover, 25% of the centers without on-site surgery performed ≤25 PCIs annually. 14, 32 A previous meta-analysis by Singh et al 6 evaluated the safety of nonprimary PCI without on-site surgery among 914 288 patients from 9 nonrandomized observational studies. Although the pooled analysis of in-hospital death rates did not differ significantly between centers with and without on-site surgery (OR, 1.15; 95% CI, 0.93-1.41), the mortality rates after adjustment of publication bias (with trim-and-fill method) were significantly higher in centers without on-site surgery (corrected OR, 1.25; 95% CI, 1.01-1.53; P=0.04). However, among the total 15 studies included in this meta-analysis, all were nonrandomized observational studies except for 1 RCT. In addition, the discrepancy between the original pooled analysis and trimand-filled adjusted analysis hinders definite conclusions regarding the nonprimary PCIs performed in centers without on-site surgery.
In contrast to previous studies, the recently published large-scale RCTs (CPORT-E and MASS COMM trial) found no significant differences in all-cause mortality and emergency surgery rates after nonprimary PCI.
2,3 The CPORT-E trial randomly assigned 14 149 patients to PCI at centers without on-site surgery and 4718 patients to PCI at centers with on-site surgery. The 6-week mortality rates (0.9% versus 1.0%; 95% CI of difference, -0.31 to 0.23; P=0.004 for noninferiority) and 9-month rates of major adverse cardiac events (all-cause mortality, Q-wave myocardial infarction, target vessel revascularization; 12.1% versus 11.2%; 95% CI of difference, 0.04-1.80; P=0.05 for noninferiority) did not differ between centers with and without on-site surgery.
The MASS COMM trial confirmed noninferiority of nonemergency PCI performed at centers without on-site surgery to centers with on-site surgery among 3691 patients. The rates of major adverse cardiac events were 9.5% and 9.4% at 30 days (relative risk, 1.00; 95% 1-sided limit, 1.22; noninferiority margin, 1.5; P<0.001 for noninferiority), and 17.3% and 17.8%, respectively, at 12 months (relative risk, 0.98; 95%
at TEL AVIV UNIV on September 28, 2015 http://circ.ahajournals.org/ Downloaded from 1-sided limit, 1.13; noninferiority margin, 1.3; P<0.001 for noninferiority).
The CPORT-E and MASS COMM trials had similar findings regarding mortality and major adverse cardiac events; however, in general, the CPORT-E population had higher risk profiles than the MASS COMM population. For example, the CPORT-E population had a relatively higher frequency of left main disease (CPORT-E versus MASS COMM: 3.4% versus 0.7%), multivessel PCI (20.9% versus 15.4%), and previous history of PCI (31.5% versus 28.5%) and coronary artery bypass grafting (13.2% versus 5.8%). Nonetheless, the safety and efficacy of PCI did not differ by presence of onsite surgery.
With the inclusion of these 2 large-scaled pivotal trials in the pooled analysis, our meta-analysis confirmed similar risks of all-cause mortality and emergency surgery after nonprimary PCI in centers without on-site surgery without evidence of publication bias. Moreover, the results were consistent across various subgroups, including ≥30% of patients with 3-vessel disease. The safety of nonprimary PCI without on-site surgical backup was also supported by very low rates of serious complications of PCI in centers without on-site surgery. To our knowledge, this is the most comprehensive meta-analysis; it includes the largest number of high-quality studies.
Of note, after 2007 to 2008, we observed a temporal trend in the effect size (OR), from greater toward equivalent risk, for all-cause mortality after nonprimary PCI in centers without on-site surgery. Possible reasons for this temporal trend are as follows. First, despite the 2007 American College of Cardiology Foundation/American Heart Association/Society for Cardiovascular Angiography and Interventions guideline containing a class III recommendation for nonprimary PCI without on-site surgical backup, many studies continue to report nonsignificant differences of outcomes, including reports about nonprimary PCI during 2006 to 2007, [16] [17] [18] and the number of PCIs performed without onsite surgery has increased since 2007 across the United States. 1 Second, the expanded use of DES since 2006 to 2007, especially secondgeneration DES with improved flexibility, deliverability, technical success rates, and safety profile (ie, significantly reduced fatal stent thrombosis rates), might explain this trend. 33 Nonetheless, this finding should be regarded as hypothesis generating.
It should be also noted that we could not evaluate target vessel revascularization (TVR), an important index of PCI efficacy, owing to the paucity and inconsistent reporting of TVR data. In the CPORT-E trial, the 9-month TVR rates after nonprimary PCI in centers without on-site surgery were significantly higher than in centers without on-site surgery, regardless of the TVR definition or stent types (6.5% versus 5.4%; P=0.01). However, the more recently published MASS COMM trial reported numerically lower, but not significantly different, rates of TVR in centers without on-site surgery at 12 months (8.5% versus 9.9%; relative risk, 0.86; 95% CI, 0.67-1.11; P=0. 24) . Pooled analysis of these 2 RCTs found no difference in TVR rates (OR, 1.04; 95% CI, 0.75-1.45; P=0.810; I 2 =78.6%). The rationale for allowing nonprimary PCI to be performed in centers without on-site surgery is to enhance patient convenience and maintain continuity of medical care; hence, further study is warranted to evaluate the impact of nonprimary PCI without on-site surgery on repeat revascularization, subsequent medical costs, and quality of life.
Limitations
Some important limitations of the current study should be considered. First, this meta-analysis included clinically and methodologically diverse studies. Although no evidence of publication or small study bias was noticed, the pooled analysis of nonprimary PCI found considerable heterogeneity. However, heterogeneity was primarily attributable to differences in the patient population and the variance of each summary measure. Studies that were conducted in the earlier period, that is, without access to improved technologies such as DES, might be the source of heterogeneity. Restricted, pooled analysis of nonprimary PCIs that included only RCTs showed much lowered heterogeneity and results similar to the full analysis. Second, because this is a study-level metaanalysis, we could not adjust for patient-level confounders and unmeasured confounders, such as operator experience; technical ability; type of medical center (private or public institution); adequacy of medical treatment, including secondary prevention; and, importantly, annual volume of PCIs performed in each institution. Third, most of the included studies categorized urgent PCI for non-STEMI as nonprimary PCI, therefore, our results might not represent clinical outcomes of elective PCI for stable angina or silent ischemia. Last, information regarding the specific measures of revascularization, for example, balloon angioplasty, bare-metal stent, and first-or second-generation DES, were reported inconsistently and partially in each of the included studies. Therefore, we could not perform analyses stratified by the method of revascularization.
Conclusions
The clinical outcomes and complication rates of patients treated with PCI at centers without on-site surgery did not differ from centers with on-site surgery, for both primary and nonprimary PCI. Temporal trends of improving clinical outcomes for nonprimary PCI at centers without onsite surgery were observed. Further studies are warranted, including the comparison of rates of repeat revascularization, medical costs, and quality of life, especially after nonprimary PCI.
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CLINICAL PERSPECTIvE
In the current era of stents, the rate of serious complications and subsequent need of emergency surgery has dramatically decreased, with an incidence of 0.1% to 0.4%. Despite this progress, the concern for performing percutaneous coronary intervention (PCI) at centers without on-site surgical backup has persisted, especially in nonprimary PCI for conditions other than ST-segment-elevation myocardial infarction. Whether PCI at centers without on-site surgical backup will increase the risk of adverse outcomes and complications remains elusive, especially for nonprimary PCI. In this updated meta-analysis with 1 101 123 patients from 23 high-quality studies, the rates of all-cause mortality, emergency coronary artery bypass graft surgery, and other complications were not different between centers with and without on-site surgery, regardless of primary or nonprimary PCI. Cumulative meta-analysis for nonprimary PCI showed temporal decrease of the difference in all-cause mortality since 2007, suggesting temporal trends of improving outcomes in nonprimary PCI at centers without on-site surgery. These results suggest the safety of PCI at centers without on-site surgical backup, for both primary and nonprimary PCI. However, because the rationale for allowing nonprimary PCI to be performed in centers without on-site surgery is to enhance patient convenience and maintain the continuity of medical care, further study is warranted to evaluate the impact of nonprimary PCI without on-site surgery on repeat revascularization, subsequent medical costs, and quality of life. References of recent reviews, editorials, and meta-analyses were also examined. No restrictions were imposed on language, study period, or sample size.
Supplementary Material
Study Selection
Studies that met each of following criteria were considered eligible for meta-analysis. First, the results including complications and clinical outcomes, including all-cause mortality or need of emergency surgery, from a center without on-site surgical back-up were clearly reported. Second, the outcomes of PCI were compared with a center with on-site surgical back-up Third, for studies focused on primary PCI, a clear definition of STEMI was reported. Last, RCT or non-randomized prospective observational studies were considered eligible. For nonrandomized prospective observational studies, statistical adjustment of baseline difference between centers with or without on-site surgical back-up was appropriately used (for example, propensity score-based adjustment, matching, covariate adjustment). We did not include studies which reported PCI outcomes without a comparison or control group. Two investigators (J.M.L and D.H) independently performed screening of titles and abstracts, identified duplicates, reviewed full articles, and determined their eligibility. Disagreements were resolved by discussion.
The last search was performed in January 2015.
Data Extraction and Quality Assessment
Summary data as reported in the published manuscripts were used in the analysis. A standardized form was used to extract characteristics of studies, study design (including randomization sequence generation, allocation concealment, crossover between assigned groups, number of post-randomization withdrawals or loss to follow-up for the RCT; inclusion and exclusion criteria, comparability of study cohort and control group, independent blind outcome assessment, length of follow-up, completeness of follow-up for non-randomized prospective observational study), number of study patients, type of PCI (primary PCI or non-primary PCI), age, clinical and angiographic eligibility criteria including clinical diagnosis, definition of STEMI, proportion of 3-vessel disease or left main vessel intervention, proportion of cardiovascular risk factors (male, hypertension, diabetes mellitus, chronic kidney disease, dyslipidemia, previous stroke, previous CABG, previous history of MI). The rates of all-cause mortality, in-hospital mortality, early mortality (within 30-day), late mortality (after 30-day), need for emergency surgery, complications related to PCI (stroke, cardiogenic shock, coronary dissection, cardiac tamponade, recurrent MI)
were collected with its definition reported on an intention-to-treat basis. Patients with STEMI did not include those with facilitated PCI or rescue PCI, and these patients were likely to be included as NSTEMI patients in the non-primary PCI group. In studies which enrolled both primary and non-primary PCI patients, sample size and number of events were separately extracted, according to the primary or non-primary PCI group. Our analysis was focused primarily on comparison of all-cause mortality, need for emergency surgery, and PCI complications between centers without on-site surgery and with on-site surgery.
The quality of eligible studies was assessed using the Cochrane Collaboration's tool for assessing the risk of bias for RCTs, the Newcastle-Ottawa Scale (NOS) and the strengthening the reporting of observational studies in epidemiology (STROBE) checklist for nonrandomized prospective observational studies. We did not exclude individual studies based on the specific threshold of NOS or STROBE checklist for the analysis.
Outcomes and Definitions
The primary outcome was the rates of all-cause mortality at the longest available follow-up. Secondary outcomes included the need for emergency surgery related to the use of PCI, all-cause mortality stratified by reported time (early mortality was defined as occurring within 30-days of the index procedure and late mortality was defined as occurring after 30-days of the index procedure), and complications of PCI (stroke, cardiogenic shock, coronary dissection, cardiac tamponade, recurrent MI). If data were duplicated between studies, the most recent study was used. All patients and outcomes were separately analyzed according to type of PCI (primary PCI or non-primary PCI), and analyzed according to the originally assigned group.
Data Synthesis and Analysis
Primary and secondary outcomes were analyzed by mixed-effects model. Odds ratio (OR) with 95% confidence intervals (CI) were presented as summary statistics. Since all included studies showed heterogeneity regarding study protocol and populations, the fixed-effects model was only used as sensitivity analyses to check whether these models yielded similar results. The pooled OR and 95% confidence intervals were calculated with the restricted maximum likelihood (REML) method for mixed-effects as well as the Mantel-Haenszel method for fixed-effects. 1 Because of progressive changes in primary study designs and clinical practice patterns, especially revascularization method (balloon angioplasty, bare metal stent, 1 st or 2 nd generation DES), we evaluated the impact of publication date on the overall effect of pooled
ORs for rates of all-cause mortality by a cumulative meta-analysis. In cumulative meta-analysis, the pooled estimate of the treatment effect is updated each time the results of a new study are added. 2 Therefore cumulative meta-analysis is the repeated performance of a meta-analysis whenever new studies become available for inclusion. Since all of the included studies in the cumulative meta-analysis had the same comparison groups, cumulative pooled estimates up to time point of last study inclusion could reflect possible temporal trends in outcome measures.
All study outcomes were separately analyzed according to primary or non-primary PCI. Statistical heterogeneity was quantified with the I 2 statistics. Publication bias was assessed by funnel plot asymmetry, along with Egger's and Begg's test and when any visual asymmetry of funnel plot was suspected, the trim-and-fill method was used to estimate the number of missing studies and to calculate a corrected OR, as if these studies were present. 3 The influence of an individual study was explored with estimating pooled OR, with stepwise exclusion of 1 study.
Subgroup analyses were performed to see whether the results were different across subgroups. Subgroup analyses were done for: (1) study protocols (RCT or prospective observational study) ; (2) proportion of 3-vessel disease (proportion < 30% or ≥ 30%) ; (3) 
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